Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer

NCT02138734 is registered in ClinicalTrials.gov with ImmunityBio, Inc. as lead sponsor.

NCT NCT02138734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02138734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer
Lead sponsor
ImmunityBio, Inc.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
July 21, 2014
Completion date
March 4, 2039
Enrollment
369 (actual)
Sites
108

Conditions

As the registry lists them; a condition with its own page is linked.

non-muscle invasive bladder cancer